China SXT Pharmaceuticals (SXTC) Shares Outstanding (2018 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Shares Outstanding (Entity) of $679648.0 for Q1 2026, up 7059.46% year-over-year from $9493.0 in Q1 2025, and down 12.18% quarter-over-quarter from $773905.0 in Q3 2025.
China SXT Pharmaceuticals (SXTC) Shares Outstanding (2018 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Shares Outstanding (Entity) history runs 9 years deep, the most recent figure standing at $679648.0 for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 7059.46% year-over-year to $679648.0; the TTM figure through Mar 2026 stood at $679648.0 (up 7059.46% YoY), while the FY2026 annual figure was $679648.0, up 7059.46% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $679648.0, down from $773905.0 in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $773905.0 in Q3 2025, with the low at $35.0 in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $723.0 (2024), against an average of $165120.3.
- The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) jumped 34.62% in 2022, then surged 7059.46% in 2026.
- China SXT Pharmaceuticals' Shares Outstanding (Entity) stood at $85.0 in 2022, then soared by 391.76% to $418.0 in 2023, then surged by 5056.22% to $21553.0 in 2024, then surged by 3490.71% to $773905.0 in 2025, then dropped by 12.18% to $679648.0 in 2026.
- Business Quant data shows SXTC's Shares Outstanding (Entity) at $679648.0 in Q1 2026, $773905.0 in Q3 2025, and $9493.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 832.44 Mn |
| 10 | China SXT Pharmaceuticals | 32,423.28 | -28.14 Mn | - | 8,496.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 679,648.00 |
| Sep 30, 2025 | 773,905.00 |
| Mar 31, 2025 | 9,493.00 |
| Sep 30, 2024 | 21,553.00 |
| Mar 31, 2024 | 723.00 |
| Sep 30, 2023 | 418.00 |
| Mar 31, 2023 | 223.00 |
| Sep 30, 2022 | 85.00 |
| Mar 31, 2022 | 35.00 |
| Sep 30, 2021 | 26.00 |
| Mar 31, 2021 | 24.00 |
| Sep 30, 2020 | 22.00 |
| Mar 31, 2020 | 10.00 |
| Sep 30, 2019 | 9.00 |
| Mar 31, 2019 | 9.00 |
| Sep 30, 2018 | 8.00 |
| Mar 31, 2018 | 8.00 |